| Name | Exarafenib |
|---|
| Description | Exarafenib (RAF/KIN_2787) is a potent, orally active pan-RAF inhibitor. Exarafenib has anticancer activity by suppression of downstream MAPK pathway signaling. Exarafenib can be used for cancer research[1][2]. |
|---|---|
| Related Catalog | |
| References |
[2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical |
| Molecular Formula | C26H34F3N5O3 |
|---|---|
| Molecular Weight | 521.58 |